Vanquish Innovation ApS
CVR 38611232 · Private limited company (ApS) · Active · Very high risk
Vanquish Innovation ApS is a Private limited company (ApS), founded on , based in Charlottenlund. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 7.8% over the next 12 months, which is 5.6 times the average for Danish companies. 9 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -855k and a net result of DKK -1,356. CEO: Valdemar Eduard Axel Siesbye.
Bankruptcy risk for Vanquish Innovation ApS
5.6 × the average (1.41%) · higher risk than 96% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 38611232
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (9 years)
- Address
- c/o Valdemar Eduard Axel Siesbye, Skovshovedvej 23A
2920 Charlottenlund - Municipality
- Gentofte
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 125k
- Employees
- 0 (2018)
- Auditor
- RevisionsFirmaet EdelboStatsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 4 of 9 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -63.2% |
| Current ratio | 24% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 2 |
| Other companies at the address | 6 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -65k | DKK -43k |
| Net profit | DKK -1,356 | DKK -50k |
| Equity | DKK -855k | DKK -853k |
| Total assets | DKK 1.4m | DKK 600k |
| Cash | DKK 95k | – |
| Short-term debt | DKK 2.0m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · RevisionsFirmaet EdelboStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 187 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 182 | ||
| 1 Jan 2023 – 31 Dec 2023 | 183 | ||
| 1 Jan 2022 – 31 Dec 2022 | 198 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 175 | ||
| 1 Jan 2020 – 31 Dec 2020 | 193 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 259 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 164 | ||
| 24 Apr 2017 – 31 Dec 2017 | 168 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Valdemar Eduard Axel Siesbye | Current | |
| Owner (100%) | VSI Invest ApS | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | VSI Invest ApS | Current |
The CEOs' other companies
Valdemar Eduard Axel Siesbye – 8 other companies, of which 3 bankrupt
- LANG CO HOLDING ApS Bankrupt 29 Mar 2010
- LANG CO LTD. ApS Bankrupt 29 Mar 2010
- TEXO MEDICAL ApS Bankrupt 6 Nov 2020
- A/S PSE NR. 1680 AF 1/8 1988 Opløst
- CVS EJENDOMME ApS Active
- CVS MELLEMHOLDNING ApS Fusioneret
- LAXO ApS Fusioneret
- VSI Invest ApS Active
Address history (3 moves)
| c/o Valdemar Eduard Axel Siesbye, Skovshovedvej 23A, 2920 Charlottenlund | |
| c/o Valdemar Eduard Axel Siesbye, Skovshovedvej 23A, 2920 Charlottenlund | |
| c/o Valdemar Eduard Axel Siesbye, Puggaardsgade 8, 4. th, 1573 København V | |
| c/o Valdemar Eduard Axel Siesbye, Grønningen 7, 6. tv, 1270 København K |
Employees per year
Other companies at the same address
- CVS EJENDOMME ApS Active
- LAXO ApS Fusioneret
- TKT Entreprise ApS Opløst
- VSI Invest ApS Active
- Vanquish Research ApS Fusioneret
- Woodshead Holding ApS Active
Similar companies in Gentofte
- SamGo Pharma ApS Hellerup
- NEUROINNOVATECH ApS Klampenborg
- Cessatech A/S Hellerup
- TLACPH Consulting ApS Charlottenlund
- Cordane ApS Hellerup
- Xtherapeutics ApS Charlottenlund
- VetInject A/S Hellerup
- Pharmagen ApS Gentofte
- AKTIESELSKABET AF 1. JUNI 2011 I Hellerup
- Ascendis Pharma Growth Disorders A/S Hellerup
- ASCENDIS PHARMA BONE DISEASES A/S Hellerup
- ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S Hellerup
Questions and answers about Vanquish Innovation ApS
Has Vanquish Innovation ApS gone bankrupt?
No, Vanquish Innovation ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Vanquish Innovation ApS?
Our model estimates a bankruptcy risk of 7.8% over the next 12 months (very high risk), which is 5.6 times the average for Danish companies.
Who is the CEO of Vanquish Innovation ApS?
Valdemar Eduard Axel Siesbye is the CEO of Vanquish Innovation ApS.
Who is the auditor of Vanquish Innovation ApS?
Vanquish Innovation ApS most recently used RevisionsFirmaet EdelboStatsautoriseret Revisionspartnerselskab.
When was Vanquish Innovation ApS founded?
Vanquish Innovation ApS was founded on 24 April 2017.
What is the equity of Vanquish Innovation ApS?
Equity was DKK -855k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.